ReviewJournal of hematology & oncology2022

Improvement of the anticancer efficacy of PD-1/PD-L1 blockade via combination therapy and PD-L1 regulation.

Mengling Wu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.